ARCHIVES

Move Starts To Strip Anticancer Drug Regulation From FDA After New Charges It Is Delaying INDs

This article is from The Cancer Letter archive.

Vol. 02 No. 42 | October 15, 1976

Download PDF Visit The Full Archive

Related Articles

Upton Prefers Keeping Bioassay Program In NCI

May 12, 1978

NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted

March 19, 1976

Larry Norton Is President-Elect Of ASCO; Rauscher Is Cancer Research Editor-In-Chief.

March 3, 2000

Sunitinib May Be Associated With Cardiac Toxicity

January 25, 2008

VTP Implementing 95% Of Ad Hoc Panel Suggestions

May 10, 1985

NCI Test Panels Available For Marker Evaluation

March 2, 1984